| |
N
|
LET + NAAT+
|
LET-NAAT+
|
LET + NAAT-
|
LET- NAAT-
|
Sens. (95 % CI)
|
Spec. (95 % CI)
|
PPV (95 % CI)
|
NPV (95 % CI)
|
Agr.
|
Kappa
|
|---|
|
LET 2 m
|
|
ALL
|
412
|
87
|
7
|
197
|
121
|
92.6 % (85.3–97.0)
|
38.1 % (32.7–43.6)
|
30.6 % (27.3–36.4)
|
94.5 % (89.1–97.8)
|
50.5 %
|
0.179
|
|
Sympto-matic patients
|
279
|
71
|
6
|
141
|
61
|
92.2 % (83.8–97.1)
|
30.2 % (24.0–37.0)
|
33.5 % (27.2–40.3)
|
91.0 % (81.5–96.6)
|
47.3 %
|
0.145
|
|
Asympto-matic patients
|
133
|
16
|
1
|
56
|
60
|
94.1 % (71.3–99.9)
|
51.7 % (42.3–61.1)
|
22.2 % (13.8–32.9)
|
98.4 % (91.2–100)
|
57.1 %
|
0.193
|
|
<25 years
|
109
|
29
|
0
|
47
|
33
|
100 % (88.1–100)
|
41.3 % (30.4–52.8)
|
38.2 % (27.2–50.0)
|
100 % (89.4–100)
|
56.9 %
|
0.272
|
|
LET 5 m
|
|
ALL
|
412
|
91
|
3
|
265
|
53
|
96.8 % (91.0–99.3)
|
16.7 % (12.7–21.2)
|
25.6 % (21.1–30.4)
|
94.6 % (85.1–98.9)
|
35.0
|
0.068
|
- *Sensitivity (Sens.), Specificity (Spec.), Positive Predictive Value (PPV), Negative Predictive Value (NPV), Agreement (Agr.) and Kappa
